The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForesight Solar Fund Regulatory News (FSFL)

Share Price Information for Foresight Solar Fund (FSFL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 89.50
Bid: 88.00
Ask: 88.60
Change: 1.60 (1.82%)
Spread: 0.60 (0.682%)
Open: 89.50
High: 89.50
Low: 89.50
Prev. Close: 87.90
FSFL Live PriceLast checked at -
Foresight Solar Fund is an Investment Trust

To provide investors with a sustainable, progressive quarterly dividend and enhanced capital value, through investment in ground based solar assets predominantly located in the UK.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q4 2019 Net Asset Value

19 Feb 2020 07:00

RNS Number : 3936D
Foresight Solar Fund Limited
19 February 2020
 

Foresight Solar Fund Limited

Q4 2019 Net Asset Value

Foresight Solar Fund Limited ("Foresight Solar" or "the Company"), a fund investing in a diversified portfolio of ground-based solar PV assets in the UK and internationally, announces that, as at 31 December 2019, its unaudited Net Asset Value ("NAV") was £626.9 million (30 September 2019: £599.4 million), resulting in a NAV per Ordinary Share of 103.6 pence (30 September 2019: 109.1 pence per share). The UK portfolio delivered a strong performance in 2019 with production 3.9% above budget.

The decrease in NAV per share is largely attributable to a significant downward revision of UK power price forecasts which resulted in a negative impact of approximately 5.5 pence per share. The updated Australian power price forecasts have had a broadly neutral impact on NAV per share for Q4 2019. In addition, and as previously announced, the results of OFGEM's Targeted Charging Review led to a decrease in NAV of 1.6 pence per share. The Company's NAV was also negatively impacted by a revaluation of the Oakey 2 asset as a result of a delay in the expected commissioning date caused by a weather incident at the end of January 2020, leading to a decrease of 1.1 pence to the NAV per share.

These movements were partially offset by a revision in the levered discount rate applied to the Company's operating assets, reflecting the competitive market for quality operational portfolios and relatively low interest rate environment, resulting in a positive impact on NAV per share of 2.2 pence. Following this revision, the Company's weighted average levered discount rate for its portfolio changed from 7.2% at 30 June 2019 to 7.1% at 31 December 2019. The Company also paid out a dividend of 1.69 pence per share during the period.

The Gross Asset Value ("GAV"), including Company and subsidiaries, as at 31 December 2019, was £1,070.4 million (30 September 2019: £1,099.9 million).

More information will be provided in the audited Annual Report which will be published on 9 March 2020.

 

For further information, please contact:

Foresight Group

Jonathon McManus +44 (0)20 3667 8147

(InstitutionalIR@ForesightGroup.eu)

 

Stifel Nicolaus Europe Limited +44 (0)20 7710 7600

Mark Bloomfield

Nick Donovan

Maarten Freeriks

 

Citigate Dewe Rogerson +44 (0)20 7638 9571

Nick Hayns

Louise Mason-Rutherford

Elizabeth Kittle

Lucy Eyles

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NAVSFIFWAESSEDE
Date   Source Headline
9th Mar 20217:00 amRNSAnnual Results to 31 December 2020
2nd Mar 20215:20 pmRNSListing pursuant to Scrip Alternative and TVR
19th Feb 20217:00 amEQSEdison Investment Research Limited: Foresight Solar Fund (FSFL): Initiation - Solar energy - the future is here
15th Feb 20214:51 pmRNSResult of General Meeting
11th Feb 20211:20 pmRNSScrip Share Price
8th Feb 20217:00 amRNSNotice of Results
28th Jan 20217:00 amRNSChange to Investment Policy and Notice of GM
27th Jan 20217:00 amRNSDeclaration of Dividend
4th Jan 20217:00 amRNSAcquisition of Spanish solar portfolio
8th Dec 20204:21 pmRNSHolding(s) in Company
2nd Dec 202012:09 pmRNSTotal Voting Rights
2nd Dec 202012:01 pmRNSDirector Shareholding
24th Nov 20207:00 amRNSListing pursuant to Scrip Alternative and TVR
13th Nov 20204:34 pmRNSDirector Shareholding
13th Nov 20207:00 amRNSQ3 2020 Net Asset Value and Operational Update
6th Nov 20209:12 amRNSScrip Share Price
4th Nov 20203:14 pmRNSHolding(s) in Company
7th Oct 20209:25 amRNSHolding(s) in Company
11th Sep 20202:43 pmRNSHolding(s) in Company
7th Sep 20207:00 amRNSAcquisition of First Spanish Solar Asset
3rd Sep 20207:00 amRNSInterim Results to 30 June 2020
2nd Sep 20203:00 pmRNSDirector/PDMR Shareholding
26th Aug 202012:07 pmRNSAdditional listing pursuant to Scrip Alternative
25th Aug 20203:41 pmRNSAppointment of Non-Executive Director
21st Aug 20201:46 pmRNSHolding(s) in Company
6th Aug 20202:39 pmRNSScrip Share Price
4th Aug 20207:00 amRNSNotice of Results
22nd Jul 20207:00 amRNSDeclaration of Dividend
16th Jul 20204:24 pmRNSResult of 2020 Annual General Meeting
8th Jul 20203:13 pmRNSDirector Shareholding
23rd Jun 20207:00 amRNSNotice of 2020 Annual General Meeting
1st Jun 202011:04 amRNSTotal Voting Rights
26th May 20204:04 pmRNSAdditional listing pursuant to Scrip Alternative
11th May 20202:33 pmRNSScrip Share Price
4th May 20207:00 amRNSQ1 2020 Net Asset Value and Operational Update
27th Mar 20207:00 amRNSCOVID-19 Update
26th Mar 20207:00 amRNSAppointment of Corporate Broker
23rd Mar 20204:43 pmRNSSecond Price Monitoring Extn
23rd Mar 20204:37 pmRNSPrice Monitoring Extension
20th Mar 20204:46 pmRNSSecond Price Monitoring Extn
20th Mar 20204:37 pmRNSPrice Monitoring Extension
9th Mar 20207:00 amRNSAnnual Results to 31 December 2019
27th Feb 20207:00 amRNSAdditional listing pursuant to Scrip Alternative
26th Feb 20207:00 amRNSRestructuring of Investment Management Arrangement
19th Feb 20207:00 amRNSQ4 2019 Net Asset Value
6th Feb 20201:59 pmRNSScrip Share Price
3rd Feb 20207:00 amRNSNotice of Results
23rd Jan 202012:08 pmRNSCORRECTION: Dividend Declaration
22nd Jan 20204:21 pmRNSDividend Declaration
29th Nov 20196:09 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.